A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy.
Arrhythmias
Electromagnetic interference
Implantable cardioverter-defibrillator
Pacemaker
Radiotherapy
Journal
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
28
01
2020
accepted:
01
06
2020
pubmed:
21
6
2020
medline:
5
5
2021
entrez:
21
6
2020
Statut:
ppublish
Résumé
High-dose 6‑MV radiotherapy may cause cardiac implantable electronic devices (CIEDs) to malfunction. To assess CIED malfunctions resulting from direct exposure up to 10 Gy, 100 pacemakers (PMs) and 40 implantable cardioverter-defibrillators (ICDs) were evaluated. CIEDs underwent baseline interrogation. In ICDs, antitachycardia therapies were disabled via the programmer while the detection windows were left enabled. A computed tomography (CT) scan was performed to build the corresponding treatment plan. CIEDs were "blinded" and randomized to receive single doses of either 2, 5, or, 10 Gy via a 6-MV linear accelerator (linac) in a water phantom. Twenty-two wireless telemetry-enabled CIEDs underwent a real-time session, and their function was recorded by the video camera in the bunker. The CIEDs were interrogated after exposure and once monthly for 6 months. During exposure, regardless of dose, 90.9% of the CIEDs recorded electromagnetic interference, with 6 ICDs (27.3%) reporting pacing inhibition and inappropriate arrhythmia detections. After exposure, a backup reset was observed in 1 PM (0.7% overall, 1% among PMs), while 7 PMs (5% overall, 7% among PMs) reported battery issues (overall immediate malfunction rate was 5.7%). During follow-up, 4 PMs (2.9% overall; 4% among PMs) and 1 ICD (0.7% overall; 2.5% among ICDs) reported abnormal battery depletion, and 1 PM (0.7% overall; 1% among PMs) reported a backup reset (overall late malfunction rate was 4.3%). Apart from transient electromagnetic interference, last-generation CIEDs withstood direct 6‑MV exposure up to 10 Gy. Permanent battery or software errors occurred immediately or later only in less recent CIEDs.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
High-dose 6‑MV radiotherapy may cause cardiac implantable electronic devices (CIEDs) to malfunction. To assess CIED malfunctions resulting from direct exposure up to 10 Gy, 100 pacemakers (PMs) and 40 implantable cardioverter-defibrillators (ICDs) were evaluated.
MATERIALS AND METHODS
METHODS
CIEDs underwent baseline interrogation. In ICDs, antitachycardia therapies were disabled via the programmer while the detection windows were left enabled. A computed tomography (CT) scan was performed to build the corresponding treatment plan. CIEDs were "blinded" and randomized to receive single doses of either 2, 5, or, 10 Gy via a 6-MV linear accelerator (linac) in a water phantom. Twenty-two wireless telemetry-enabled CIEDs underwent a real-time session, and their function was recorded by the video camera in the bunker. The CIEDs were interrogated after exposure and once monthly for 6 months.
RESULTS
RESULTS
During exposure, regardless of dose, 90.9% of the CIEDs recorded electromagnetic interference, with 6 ICDs (27.3%) reporting pacing inhibition and inappropriate arrhythmia detections. After exposure, a backup reset was observed in 1 PM (0.7% overall, 1% among PMs), while 7 PMs (5% overall, 7% among PMs) reported battery issues (overall immediate malfunction rate was 5.7%). During follow-up, 4 PMs (2.9% overall; 4% among PMs) and 1 ICD (0.7% overall; 2.5% among ICDs) reported abnormal battery depletion, and 1 PM (0.7% overall; 1% among PMs) reported a backup reset (overall late malfunction rate was 4.3%).
CONCLUSION
CONCLUSIONS
Apart from transient electromagnetic interference, last-generation CIEDs withstood direct 6‑MV exposure up to 10 Gy. Permanent battery or software errors occurred immediately or later only in less recent CIEDs.
Identifiants
pubmed: 32561941
doi: 10.1007/s00066-020-01651-7
pii: 10.1007/s00066-020-01651-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
198-208Références
Mond HG, Proclemer A (2011) The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009—a world society of arrhythmia’s project. Pacing Clin Electrophysiol 34:1013–1027. https://doi.org/10.1111/j.1540-8159.2011.03150.x
doi: 10.1111/j.1540-8159.2011.03150.x
pubmed: 21707667
Køber L, Thune JJ, Nielsen CJ, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375(13):1221–1230. https://doi.org/10.1056/NEJMoa1608029
doi: 10.1056/NEJMoa1608029
pubmed: 27571011
Jukema WJ, Timal RJ, Rotmans JI, Hensen LCR, Buiten MS, de Bie MK, Putter H, Zwinderman AH, van Erven L, Krol-van Straaten MJ, Hommes N, Gabreëls B, van Dorp W, van Dam B, Herzog CA, Schalij MJ, Rabelink TJ, ICD2 Trial Investigators (2019) Prophylactic of Implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients. Circulation 139(23):2628–2638. https://doi.org/10.1161/circulationaha.119.039818
doi: 10.1161/circulationaha.119.039818
pubmed: 30882234
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. https://doi.org/10.3322/caac.20107
doi: 10.3322/caac.20107
pubmed: 21296855
Passman R, Kadish A (2007) Sudden death prevention with implantable devices. Circulation 116:561–571. https://doi.org/10.1161/circulationaha.106.655704
doi: 10.1161/circulationaha.106.655704
pubmed: 17664385
Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, Dickfeld TML, Froelich JW, Grant J, Hayes DL, Heidbuchel H, Idriss SF, Kanal E, Lampert R, Machado CE, Mandrola JM, Nazarian S, Patton KK, Rozner MA, Russo RJ, Shen WK, Shinbane JS, Teo WS, Uribe W, Verma A, Wilkoff BL, Woodard PK (2017) 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm 14:e97–e153. https://doi.org/10.1016/j.hrthm.2017.04.025
doi: 10.1016/j.hrthm.2017.04.025
pubmed: 28502708
Nazarian S, Hansford R, Rahsepar AA, Weltin V, McVeigh D, Gucuk Ipek E, Kwan A, Berger RD, Calkins H, Lardo AC, Kraut MA, Kamel IR, Zimmermann SL, Halperin HR (2017) Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med 377:2555–2564. https://doi.org/10.1056/NEJMoa1604267
doi: 10.1056/NEJMoa1604267
pubmed: 5894885
pmcid: 5894885
Hurkmans CW, Scheepers E, Springorum BG, Ulterwaal H (2005) Influence of radiotherapy on the latest generation of implantable cardioverter defibrillators. Int J Radiat Oncol Biol Phys 63:282–289. https://doi.org/10.1016/j.ijrobp.2005.04.047
doi: 10.1016/j.ijrobp.2005.04.047
pubmed: 16111598
Zaremba T, Jakobsen AR, Thoegersen AM, Oddershede L, Riahi S (2014) The effects of radiotherapy beam energy on modern cardiac devices: an in vitro study. Europace 16:612–616. https://doi.org/10.1093/europace/eut249
doi: 10.1093/europace/eut249
pubmed: 23933852
Bagur R, Chamula M, Brouillard E, Lavoie C, Nombela-Franco L, Julien AS, Archambauld L, Varfalvy N, Gaudreault V, Jonkas SX, Israeli Z, Parviz Y, Mamas MA, Lavi S (2017) Radiotherapy-induced cardiac implantable electronic device dysfunction in patients with cancer. Am J Cardiol 119(2):284–289. https://doi.org/10.1016/j.amjcard.2016.09.036
doi: 10.1016/j.amjcard.2016.09.036
pubmed: 27823600
Makkar A, Prisciandaro J, Agarwal S, Lusk M, Horwood L, Moran J, Fox C, Hayman JA, Ghanbari H, Roberts B, Belardi D, Latchamsetty R, Crawford T, Good E, Jongnarangsin K, Bogun F, Chugh A, Oral H, Morady F, Pelosi Jr (2012) Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function. Heart Rhythm 9(12):1964–1968. https://doi.org/10.1016/j.hrthm.2012.08.018
doi: 10.1016/j.hrthm.2012.08.018
pubmed: 23102626
Brambatti M, Mathew R, Strang B, Dean J, Goyal A, Hayward JE, Long L, DeMeis P, Smoke M, Connolly SJ, Morillo CA, Amit G, Capucci A, Healey JS (2015) Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy. Heart Rhythm 12(10):2148–2154. https://doi.org/10.1016/j.hrthm.2015.06.003
doi: 10.1016/j.hrthm.2015.06.003
pubmed: 26049049
Zecchin M, Morea G, Severgnini M, Sergi E, Roldan AB, Bianco E, Magnani S, De Luca A, Zorzin Fantasia A, Salvatore L, Milan V, Giannini G, Sinagra G (2016) Malfunction of cardiac devices after radiotherapy without direct exposure to ionizing radiation: mechanisms and experimental data. Europace 18(2):288–293. https://doi.org/10.1093/europace/euv250
doi: 10.1093/europace/euv250
pubmed: 26333380
Marbach JR, Sontag MR, Van Dyk J, Wolbarst AB (1994) Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM task group no. 34. American association of physicists in medicine. Med Phys 21:85–90
doi: 10.1118/1.597259
Hurkmans CW, Knegiens JL, Oei BS, Maas AJ, Uiterwaal GJ, van der Borden AJ, Ploegmakers MM, van Erven L, Dutch Society of Radiotherapy and Oncology (2012) Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Radiat Oncol 7:198
doi: 10.1186/1748-717X-7-198
Zecchin M, Severgnini M, Fiorentino A, Malavasi VL, Menegotti L, Alonghi F, Catanzariti D, Jereczek-Fossa BA, Stasi M, Russi E, Boriani G (2018) Management of patients with cardiac implantable devices (CIED) undergoing radiotherapy. A consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM). Int J Cardiol 255:175–183. https://doi.org/10.1016/ijcard.2017.12.061
doi: 10.1016/ijcard.2017.12.061
pubmed: 29310933
Gauter-Fleckenstein B, Israel CW, Dorenkamp M, Dunst J, Roser M, Schimpf R, Steil V, Schäfer J, Höller U, Wenzet F (2015) DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices. Strahlenther Onkol 191:393–404. https://doi.org/10.1007/s00066-015-0817-3
doi: 10.1007/s00066-015-0817-3
pubmed: 25739476
Lenarczyk R, Potpara TS, Haugaa KH, Deharo JC, Hernandez-Madrid A, Exposido Pineda MC, Kiliszek M, Dagres N (2017) Approach to cardio-oncologia patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European heart rhythm association survey. EP. Europace 19(9):1579–1584. https://doi.org/10.1093/europace/eux195
doi: 10.1093/europace/eux195
pubmed: 28934410
Miften M et al (2019) Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: a report of the AAPM TG-203. Med Phys. https://doi.org/10.1002/mp.13838
doi: 10.1002/mp.13838
pubmed: 31622500
pmcid: 6625917
Borras JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, Grau C (2016) How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol 119(1):5–11. https://doi.org/10.1016/S0167-8140(16)31580-8
doi: 10.1016/S0167-8140(16)31580-8
pubmed: 26922487
Kapa S, Fong L, Blackwell CR, Hermann MG, Schomberg PJ, Hayes DL (2008) Effects of scatter radiation on ICD and CRT function. Pacing Clin Electrophysiol 31:727–732. https://doi.org/10.1111/j.1540-8159.2008.01077.x
doi: 10.1111/j.1540-8159.2008.01077.x
pubmed: 18507546
Hashimoto T, Isobe T, Hashii H, Kumada H, Tada H, Okumura T, Tsuboi K, Sakae T, Aonuma K, Sakurai H (2012) Influence of secondary neutrons induced by photon radiotherapy for cancer patients with implantable cardioverter defibrillator. Radiat Oncol 7:10. https://doi.org/10.1186/1748-717X-7-10
doi: 10.1186/1748-717X-7-10
pubmed: 22284700
pmcid: 3283465
Zecchin M, Artico J, Morea G, Severgnini M, Bianco E, De Luca A, Zorzin Fantasia A, Salvatore L, Milan V, Lucarelli M, Dissegna R, Cannatà A, Sinagra G (2018) Radiotherapy and risk of implantable cardioverter-defibrillator malfunctions: experimental data from direct exposure at increasing doses. J Cardiovasc Med 19(4):155–160. https://doi.org/10.2459/jcm.2018.000000000623
doi: 10.2459/jcm.2018.000000000623
Zaremba T, Jakobsen AR, Sogaard M, Thoegersen AM, Riahi S (2016) Radiotherapy in patients with pacemakers and implantable cardioverter defibrillator: a literature review. Europace 18:479–491. https://doi.org/10.1093/europace/euv135
doi: 10.1093/europace/euv135
pubmed: 26041870
Zaremba T, Jakobsen AR, Sogaard M, Thoegersen AM, Riahi S (2015) Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study. Pacing Clin Electrophysiol 38:343–356. https://doi.org/10.1111/pace.12572
doi: 10.1111/pace.12572
pubmed: 25601489
Hauser RG, Kallinen L (2004) Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States food and drug administration manufacturer and user facility device experience database. Heart Rhythm 1:399–405. https://doi.org/10.1001/jamaoncol.2015.1787
doi: 10.1001/jamaoncol.2015.1787
pubmed: 15851191
Gifford J, Larimer K, Thomas C, May P, Stanhope S, Gami A (2014) Randomized controlled trial of perioperative ICD management: magnet application versus reprogramming. Pacing Clin Electrophysiol 37:1219–1224. https://doi.org/10.1111/pace.12417
doi: 10.1111/pace.12417
pubmed: 24802626
Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, Ferguson TB Jr, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, Moorman LP, Thompson A (2011) The heart rhythm society (HRS)/American society of anaesthesiologists (ASA) expert consensus statement on the perioperative management of patients with Implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management. Heart Rhythm 8(7):1114–1154. https://doi.org/10.1016/j.hrthm.2010.12.023
doi: 10.1016/j.hrthm.2010.12.023
pubmed: 21722856
Grant JD, Jensen GL, Tang C, Pollard JM, Kry SF, Krishnan S, Dougherty AH, Gomez DR, Rozner MA (2015) Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices: clinical incidence and predictors. JAMA Oncol 1(5):624–632. https://doi.org/10.1001/jamaoncol.2015.1787
doi: 10.1001/jamaoncol.2015.1787
pubmed: 26181143
Yeung C, Hazim B, Campbell D, Gooding J, Li SXL, Tam HK, Hopman WM, Chako S, Redfearn DP, Simpson C, Abdollah H, Baranchuk A (2019) Radiotherapy for patients with cardiovascular implantable electronic devices: an 11-year experience. J Interv Card Electrophysiol 55(3):333–341. https://doi.org/10.1007/s10840-018-0506-0
doi: 10.1007/s10840-018-0506-0
pubmed: 30603854
Salerno F, Gomellini S, Caruso C, Barbara R, Musio D, Coppi T, Cardinale M, Tombolini V, de Paula U (2016) Management of radiation therapy patients with cardiac defibrillator or pacemaker. Radiol Med 121(6):515–520. https://doi.org/10.1007/s11547-015-0616-z
doi: 10.1007/s11547-015-0616-z
pubmed: 26706454